Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population

Taro Kishi, Yasuhisa Fukuo, Reiji Yoshimura, Tomo Okochi, Tsuyoshi Kitajima, Hiroshi Naitoh, Wakako Umene-Nakano, Jun Nakamura, Norio Ozaki, Nakao Iwata

研究成果: Article

13 引用 (Scopus)

抄録

Objective: Several investigations have suggested that alterations in serotonin 6 (5-HT6) receptors might be associated with the pathophysiology of major depressive disorder (MDD), and that 5-HT6 receptors might be a therapeutic target for serotonin selective reuptake inhibitor (SSRI) in MDD. To evaluate the association between HTR6 and the efficacy of SSRI treatment in Japanese MDD patients, we conducted a case-control study in a Japanese population sample. Methods: We selected five tagging SNPs (rs6693503, rs1805054, rs4912138, rs3790757 and rs9659997), and performed an association analysis of HTR6 and the efficacy of SSRI treatment in 260 MDD patients. Results: We did not detect an association between tagging SNPs in HTR6 and the therapeutic response to SSRI inMDD in allele/genotype or haplotype analysis. Conclusions: HTR6 may not play an important role in the pathophysiology of SSRI response in the Japanese population. Because our sample was relatively small, statistical errors were possible in the results of our association analyses. To overcome these limitations, a replication study using a larger sample may be required for conclusive results.

元の言語English
ページ(範囲)481-486
ページ数6
ジャーナルHuman Psychopharmacology
25
発行部数6
DOI
出版物ステータスPublished - 01-08-2010

Fingerprint

Major Depressive Disorder
Serotonin Uptake Inhibitors
Antidepressive Agents
Population
Genes
Single Nucleotide Polymorphism
Therapeutics
Haplotypes
Case-Control Studies
Serotonin
Alleles
Genotype
Pharmacogenomic Testing
serotonin 6 receptor

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Psychiatry and Mental health
  • Neurology
  • Pharmacology (medical)

これを引用

Kishi, Taro ; Fukuo, Yasuhisa ; Yoshimura, Reiji ; Okochi, Tomo ; Kitajima, Tsuyoshi ; Naitoh, Hiroshi ; Umene-Nakano, Wakako ; Nakamura, Jun ; Ozaki, Norio ; Iwata, Nakao. / Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population. :: Human Psychopharmacology. 2010 ; 巻 25, 番号 6. pp. 481-486.
@article{66108d198d9a424c8e20588a0f069f39,
title = "Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population",
abstract = "Objective: Several investigations have suggested that alterations in serotonin 6 (5-HT6) receptors might be associated with the pathophysiology of major depressive disorder (MDD), and that 5-HT6 receptors might be a therapeutic target for serotonin selective reuptake inhibitor (SSRI) in MDD. To evaluate the association between HTR6 and the efficacy of SSRI treatment in Japanese MDD patients, we conducted a case-control study in a Japanese population sample. Methods: We selected five tagging SNPs (rs6693503, rs1805054, rs4912138, rs3790757 and rs9659997), and performed an association analysis of HTR6 and the efficacy of SSRI treatment in 260 MDD patients. Results: We did not detect an association between tagging SNPs in HTR6 and the therapeutic response to SSRI inMDD in allele/genotype or haplotype analysis. Conclusions: HTR6 may not play an important role in the pathophysiology of SSRI response in the Japanese population. Because our sample was relatively small, statistical errors were possible in the results of our association analyses. To overcome these limitations, a replication study using a larger sample may be required for conclusive results.",
author = "Taro Kishi and Yasuhisa Fukuo and Reiji Yoshimura and Tomo Okochi and Tsuyoshi Kitajima and Hiroshi Naitoh and Wakako Umene-Nakano and Jun Nakamura and Norio Ozaki and Nakao Iwata",
year = "2010",
month = "8",
day = "1",
doi = "10.1002/hup.1142",
language = "English",
volume = "25",
pages = "481--486",
journal = "Human Psychopharmacology",
issn = "0885-6222",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population. / Kishi, Taro; Fukuo, Yasuhisa; Yoshimura, Reiji; Okochi, Tomo; Kitajima, Tsuyoshi; Naitoh, Hiroshi; Umene-Nakano, Wakako; Nakamura, Jun; Ozaki, Norio; Iwata, Nakao.

:: Human Psychopharmacology, 巻 25, 番号 6, 01.08.2010, p. 481-486.

研究成果: Article

TY - JOUR

T1 - Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population

AU - Kishi, Taro

AU - Fukuo, Yasuhisa

AU - Yoshimura, Reiji

AU - Okochi, Tomo

AU - Kitajima, Tsuyoshi

AU - Naitoh, Hiroshi

AU - Umene-Nakano, Wakako

AU - Nakamura, Jun

AU - Ozaki, Norio

AU - Iwata, Nakao

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Objective: Several investigations have suggested that alterations in serotonin 6 (5-HT6) receptors might be associated with the pathophysiology of major depressive disorder (MDD), and that 5-HT6 receptors might be a therapeutic target for serotonin selective reuptake inhibitor (SSRI) in MDD. To evaluate the association between HTR6 and the efficacy of SSRI treatment in Japanese MDD patients, we conducted a case-control study in a Japanese population sample. Methods: We selected five tagging SNPs (rs6693503, rs1805054, rs4912138, rs3790757 and rs9659997), and performed an association analysis of HTR6 and the efficacy of SSRI treatment in 260 MDD patients. Results: We did not detect an association between tagging SNPs in HTR6 and the therapeutic response to SSRI inMDD in allele/genotype or haplotype analysis. Conclusions: HTR6 may not play an important role in the pathophysiology of SSRI response in the Japanese population. Because our sample was relatively small, statistical errors were possible in the results of our association analyses. To overcome these limitations, a replication study using a larger sample may be required for conclusive results.

AB - Objective: Several investigations have suggested that alterations in serotonin 6 (5-HT6) receptors might be associated with the pathophysiology of major depressive disorder (MDD), and that 5-HT6 receptors might be a therapeutic target for serotonin selective reuptake inhibitor (SSRI) in MDD. To evaluate the association between HTR6 and the efficacy of SSRI treatment in Japanese MDD patients, we conducted a case-control study in a Japanese population sample. Methods: We selected five tagging SNPs (rs6693503, rs1805054, rs4912138, rs3790757 and rs9659997), and performed an association analysis of HTR6 and the efficacy of SSRI treatment in 260 MDD patients. Results: We did not detect an association between tagging SNPs in HTR6 and the therapeutic response to SSRI inMDD in allele/genotype or haplotype analysis. Conclusions: HTR6 may not play an important role in the pathophysiology of SSRI response in the Japanese population. Because our sample was relatively small, statistical errors were possible in the results of our association analyses. To overcome these limitations, a replication study using a larger sample may be required for conclusive results.

UR - http://www.scopus.com/inward/record.url?scp=77956573720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956573720&partnerID=8YFLogxK

U2 - 10.1002/hup.1142

DO - 10.1002/hup.1142

M3 - Article

C2 - 20737521

AN - SCOPUS:77956573720

VL - 25

SP - 481

EP - 486

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 6

ER -